Drug Discovery

Artificial intelligence
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Drug targets #Machine learning

Can artificial intelligence help craft new medicines?

Listen to this article on the DDW Podcast: Professor Sonika Bhatnagar explores how artificial intelligence is enabling drug discovery at rates never seen before. A bullet for cure The year was 1907, and Paul Ehrlich, the German Nobel laureate had proposed the idea of… Read More

#Exclusive Content

Adcendo Lab
#Antibodies #Antibody drug conjugate (ADC) #Biotech #Drug development #Seed funding

Financing ensures development of Adcendo’s ADC asset 

Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, has completed a successful Series A extension financing round, raising a further €31 million, following the €51 million Series A financing in April 2021. Read More

#News

Cancer cell
#Cancer #Drug development #Oncology #Pharma

Scientific Affairs Group expands to over 200 oncologists  

Drug development company Ellipses Pharma now has more than 200 oncology experts from 106 institutions worldwide providing analysis and advice on selection of the most promising potential cancer medicines in its Scientific Affairs Group (SAG).   The number of experts joining the SAG has increased by 53% in… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

Podcast: This week’s drug discovery highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Each of our top five stories this week exemplify the scientific curiosity that fuels the drug… Read More

#News

#Drug development #Drug discovery #Emulate #Organ-on-a-chip

An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights and endpoint analyses… Read More

#Resources

#Drug development #Drug discovery #eBook #Emulate #Organ-on-a-chip

eBook: An introduction to organ-on-a-chip technology

Download Emulate’s Introduction to Organ-on-a-Chip Technology eBook to learn about: What Organ-Chips are, how they work, and why they are transforming the way drugs are discovered and developed How Organ-Chips overcome the main challenges of conventional in vivo and in vitro models The wide variety of insights… Read More

#News

#Anxiety disorder #Diabetes #Drug development #Drug discovery #Geographic atrophy #HIV #Lung cancer #Oncology

This week in drug discovery (24-28 April)

News round-up for 24-28 April by DDW Digital Content Editor Diana Spencer. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to… Read More

#News

#Cloud computing #Drug discovery #Pathology #R&D #Software

Software aiming to improve efficiency of drug R&D 

A cloud-based digital pathology platform has helped a CRO deliver more informed preclinical studies.  Proscia announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research.   Context  90% of drug candidates fail during clinical trials.1 This… Read More

#News

Amygdala
#Anxiety disorder #Drug discovery #Neuroscience #Preclinical investigations #University of Bristol #University of Exeter

Discovery represents the ‘first step’ to better anti-anxiety drugs

A team of scientists have discovered that modification of a gene in the brain can reduce anxiety levels, offering an exciting novel drug target for anxiety disorders. The discovery, led by researchers at the Universities of Bristol and Exeter in the UK, is published in Nature… Read More

#News

#DNA #Drug discovery #INTEGRA #Laboratory #PCR

eBook: Learn how to become a PCR pro

The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive… Read More

#News

#DNA #Drug discovery #INTEGRA #Laboratory #PCR

How to become a PCR pro

The term ‘PCR’ has been on everybody’s lips since the outbreak of the Covid-19 pandemic, but only laboratory professionals know how difficult it can be to achieve success with this well-established technique. If your PCR reactions are driving you to despair, look no further than INTEGRA’s comprehensive eBook! Learn more… Read More

#Resources

#Absci #AI / data analytics / healthtech / informatics #Antibodies #Artificial intelligence (AI) #Drug discovery #Interview

How generative AI could improve drug discovery

Listen to this article on the DDW Podcast: Absci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly. Here, DDW Editor Reece Armstrong speaks to Sean McClain, the Founder and CEO of Absci about how generative AI… Read More

#Exclusive Content

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download this new mitochondrial toxicity infographic by Agilent and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. The infographic will help you: Gain an historical perspective on mitochondrial… Read More

#News

#Agilent #Biosafety testing #Drug discovery #In vivo #Infographic #Mitochondria

Learn new ways to identify mitochondrial liability

Download our mitochondrial toxicity infographic and discover the benefits of novel in vitro strategies for consumer safety. Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals. Our infographic will help you: Gain an historical perspective on mitochondrial toxicity. Understand the importance of testing… Read More

#Intelligence #Resources

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Global start-ups: where is the innovation?

Listen to this article on the DDW Podcast: DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. UK Budget a ‘shot in the arm’ for oncology start-ups Before the UK announced… Read More

#Exclusive Content #Start-up Zone

#AACR 2023 #Cancer research #Cancer vaccine #Drug discovery #Oncology

New podcast episode: DDW Highlights

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The news stories dominating the headlines this week have been the breaking developments in cancer drug… Read More

#News